{
    "2020-05-04": [
        [
            {
                "time": "",
                "original_text": "年报季后，国泰君安上调目标价超过20%的公司名单 | 国君研究",
                "features": {
                    "keywords": [
                        "年报",
                        "国泰君安",
                        "目标价",
                        "上调"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "交银国际：升复星医药(2196.HK)目标价至34港元 评级“买入”",
                "features": {
                    "keywords": [
                        "交银国际",
                        "复星医药",
                        "目标价",
                        "买入"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "4月日均融券余额突破200亿元创新高，这一行业这一个股最受融资客青睐！",
                "features": {
                    "keywords": [
                        "4月",
                        "融券余额",
                        "创新高",
                        "行业",
                        "个股"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "交银国际：复星医药目标价升至34港元 维持买入评级",
                "features": {
                    "keywords": [
                        "交银国际",
                        "复星医药",
                        "目标价",
                        "买入"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "复星医药(02196)主体及若干公司债券信用等级为AAA",
                "features": {
                    "keywords": [
                        "复星医药",
                        "债券",
                        "信用等级",
                        "AAA"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "交银国际：升复星医药(02196)目标价至34港元 维持“买入”评级",
                "features": {
                    "keywords": [
                        "交银国际",
                        "复星医药",
                        "目标价",
                        "买入"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "格隆汇港股通5日资金流入流出排行榜 | 5月3日",
                "features": {
                    "keywords": [
                        "格隆汇",
                        "港股通",
                        "资金流入",
                        "资金流出",
                        "排行榜"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}